Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 78 entries
Sorted by: Best Match Show Resources per page
Carcinoid syndrome from a carcinoid tumor of the pancreas without liver metastases: A case report and literature review.

Oncology letters

Zavras N, Schizas D, Machairas N, Damaskou V, Economopoulos N, Machairas A.
PMID: 28454406
Oncol Lett. 2017 Apr;13(4):2373-2376. doi: 10.3892/ol.2017.5678. Epub 2017 Feb 06.

A carcinoid tumor of the pancreas (CTP) is a rare pancreatic neoplasm, and usually presents with carcinoid syndrome (CS). CS consists of the classic symptom triad of cutaneous flushing, diarrhea and valvular disease, and occurs in the majority of...

Cite
Zavras N, Schizas D, Machairas N, et al. Carcinoid syndrome from a carcinoid tumor of the pancreas without liver metastases: A case report and literature review. Oncol Lett. 2017;13(4):2373-2376doi: 10.3892/ol.2017.5678.
Zavras, N., Schizas, D., Machairas, N., Damaskou, V., Economopoulos, N., & Machairas, A. (2017). Carcinoid syndrome from a carcinoid tumor of the pancreas without liver metastases: A case report and literature review. Oncology letters, 13(4), 2373-2376. https://doi.org/10.3892/ol.2017.5678
Zavras, Nikolaos, et al. "Carcinoid syndrome from a carcinoid tumor of the pancreas without liver metastases: A case report and literature review." Oncology letters vol. 13,4 (2017): 2373-2376. doi: https://doi.org/10.3892/ol.2017.5678
Zavras N, Schizas D, Machairas N, Damaskou V, Economopoulos N, Machairas A. Carcinoid syndrome from a carcinoid tumor of the pancreas without liver metastases: A case report and literature review. Oncol Lett. 2017 Apr;13(4):2373-2376. doi: 10.3892/ol.2017.5678. Epub 2017 Feb 06. PMID: 28454406; PMCID: PMC5403383.
Copy Download .nbib Format: NLM
Inflammatory bowel disease-the role of cross-sectional imaging techniques in the investigation of the small bowel.

Insights into imaging

Athanasakos A, Mazioti A, Economopoulos N, Kontopoulou C, Stathis G, Filippiadis D, Spyridopoulos T, Alexopoulou E.
PMID: 25537967
Insights Imaging. 2015 Feb;6(1):73-83. doi: 10.1007/s13244-014-0377-6. Epub 2014 Dec 24.

BACKGROUND: The diagnosis of inflammatory bowel disease (IBD) in children and adolescents is based on the integration of clinical, biological, endoscopic, histological and radiological data.METHODS: The most important part of the diagnosis is the histology, which is acquired by...

Cite
Athanasakos A, Mazioti A, Economopoulos N, et al. Inflammatory bowel disease-the role of cross-sectional imaging techniques in the investigation of the small bowel. Insights Imaging. 2014;6(1):73-83doi: 10.1007/s13244-014-0377-6.
Athanasakos, A., Mazioti, A., Economopoulos, N., Kontopoulou, C., Stathis, G., Filippiadis, D., Spyridopoulos, T., & Alexopoulou, E. (2015). Inflammatory bowel disease-the role of cross-sectional imaging techniques in the investigation of the small bowel. Insights into imaging, 6(1), 73-83. https://doi.org/10.1007/s13244-014-0377-6
Athanasakos, Athanasios, et al. "Inflammatory bowel disease-the role of cross-sectional imaging techniques in the investigation of the small bowel." Insights into imaging vol. 6,1 (2015): 73-83. doi: https://doi.org/10.1007/s13244-014-0377-6
Athanasakos A, Mazioti A, Economopoulos N, Kontopoulou C, Stathis G, Filippiadis D, Spyridopoulos T, Alexopoulou E. Inflammatory bowel disease-the role of cross-sectional imaging techniques in the investigation of the small bowel. Insights Imaging. 2015 Feb;6(1):73-83. doi: 10.1007/s13244-014-0377-6. Epub 2014 Dec 24. PMID: 25537967; PMCID: PMC4330227.
Copy Download .nbib Format: NLM
Exfoliation and chemical modification using microwave irradiation affording highly functionalized graphene.

ACS nano

Economopoulos SP, Rotas G, Miyata Y, Shinohara H, Tagmatarchis N.
PMID: 21080708
ACS Nano. 2010 Dec 28;4(12):7499-507. doi: 10.1021/nn101735e. Epub 2010 Nov 16.

Efficient exfoliation of graphite flakes by sonicating them in benzylamine was accomplished, affording stable suspensions of few-layers graphene. The latter were chemically modified following the Bingel reaction conditions, with the aid of microwave irradiation, producing highly functionalized graphene-based hybrid...

Cite
Economopoulos SP, Rotas G, Miyata Y, et al. Exfoliation and chemical modification using microwave irradiation affording highly functionalized graphene. ACS Nano. 2010;4(12):7499-507doi: 10.1021/nn101735e.
Economopoulos, S. P., Rotas, G., Miyata, Y., Shinohara, H., & Tagmatarchis, N. (2010). Exfoliation and chemical modification using microwave irradiation affording highly functionalized graphene. ACS nano, 4(12), 7499-507. https://doi.org/10.1021/nn101735e
Economopoulos, Solon P, et al. "Exfoliation and chemical modification using microwave irradiation affording highly functionalized graphene." ACS nano vol. 4,12 (2010): 7499-507. doi: https://doi.org/10.1021/nn101735e
Economopoulos SP, Rotas G, Miyata Y, Shinohara H, Tagmatarchis N. Exfoliation and chemical modification using microwave irradiation affording highly functionalized graphene. ACS Nano. 2010 Dec 28;4(12):7499-507. doi: 10.1021/nn101735e. Epub 2010 Nov 16. PMID: 21080708.
Copy Download .nbib Format: NLM
Cutaneous involvement in angioimmunoblastic T-cell lymphoma.

Indian journal of dermatology

Papadavid E, Panayiotides I, Dalamaga M, Katoulis A, Economopoulos T, Stavrianeas N.
PMID: 21063526
Indian J Dermatol. 2010 Jul-Sep;55(3):279-80. doi: 10.4103/0019-5154.70704.

Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive non-Hodgkin's nodal peripheral T-cell lymphoma characterized by general lymphadenopathy, night sweats, fever, hepatosplenomegaly, polyclonal hypergammaglobulinemia, and cutaneous involvement. We present a rare case of AITL cutaneous involvement mimicking toxic erythema recurring with...

Cite
Papadavid E, Panayiotides I, Dalamaga M, et al. Cutaneous involvement in angioimmunoblastic T-cell lymphoma. Indian J Dermatol. 2010;55(3):279-80doi: 10.4103/0019-5154.70704.
Papadavid, E., Panayiotides, I., Dalamaga, M., Katoulis, A., Economopoulos, T., & Stavrianeas, N. (2010). Cutaneous involvement in angioimmunoblastic T-cell lymphoma. Indian journal of dermatology, 55(3), 279-80. https://doi.org/10.4103/0019-5154.70704
Papadavid, Evangelia, et al. "Cutaneous involvement in angioimmunoblastic T-cell lymphoma." Indian journal of dermatology vol. 55,3 (2010): 279-80. doi: https://doi.org/10.4103/0019-5154.70704
Papadavid E, Panayiotides I, Dalamaga M, Katoulis A, Economopoulos T, Stavrianeas N. Cutaneous involvement in angioimmunoblastic T-cell lymphoma. Indian J Dermatol. 2010 Jul-Sep;55(3):279-80. doi: 10.4103/0019-5154.70704. PMID: 21063526; PMCID: PMC2965920.
Copy Download .nbib Format: NLM
Chemical functionalization of exfoliated graphene.

Chemistry (Weinheim an der Bergstrasse, Germany)

Economopoulos SP, Tagmatarchis N.
PMID: 24019007
Chemistry. 2013 Sep 23;19(39):12930-6. doi: 10.1002/chem.201302358. Epub 2013 Sep 09.

Graphene is turning out to be the material that will effectively kick-start a new era for nanotechnology. The impressive properties of this atom-thick carbon layer are taking shape and form with early reports of successful applications based on it....

Cite
Economopoulos SP, Tagmatarchis N. Chemical functionalization of exfoliated graphene. Chemistry. 2013;19(39):12930-6doi: 10.1002/chem.201302358.
Economopoulos, S. P., & Tagmatarchis, N. (2013). Chemical functionalization of exfoliated graphene. Chemistry (Weinheim an der Bergstrasse, Germany), 19(39), 12930-6. https://doi.org/10.1002/chem.201302358
Economopoulos, Solon P, and Tagmatarchis, Nikos. "Chemical functionalization of exfoliated graphene." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 19,39 (2013): 12930-6. doi: https://doi.org/10.1002/chem.201302358
Economopoulos SP, Tagmatarchis N. Chemical functionalization of exfoliated graphene. Chemistry. 2013 Sep 23;19(39):12930-6. doi: 10.1002/chem.201302358. Epub 2013 Sep 09. PMID: 24019007.
Copy Download .nbib Format: NLM
The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients.

Experimental hematology & oncology

Koumarianou A, Christodoulou MI, Patapis P, Papadopoulos I, Liakata E, Giagini A, Stavropoulou A, Poulakaki N, Tountas N, Xiros N, Economopoulos T, Pectasides D, Tsitsilonis OE, Pappa V.
PMID: 24456704
Exp Hematol Oncol. 2014 Jan 23;3(1):3. doi: 10.1186/2162-3619-3-3.

BACKGROUND: The host's immune system is crucially involved in cancer development and progression. The ratio of regulatory to effector T-cells, as well as the interplay of T-cells with therapeutic agents, impact on cancer prognosis. The current study aimed to...

Cite
Koumarianou A, Christodoulou MI, Patapis P, et al. The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients. Exp Hematol Oncol. 2014;3(1):3doi: 10.1186/2162-3619-3-3.
Koumarianou, A., Christodoulou, M. I., Patapis, P., Papadopoulos, I., Liakata, E., Giagini, A., Stavropoulou, A., Poulakaki, N., Tountas, N., Xiros, N., Economopoulos, T., Pectasides, D., Tsitsilonis, O. E., & Pappa, V. (2014). The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients. Experimental hematology & oncology, 3(1), 3. https://doi.org/10.1186/2162-3619-3-3
Koumarianou, Anna, et al. "The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients." Experimental hematology & oncology vol. 3,1 (2014): 3. doi: https://doi.org/10.1186/2162-3619-3-3
Koumarianou A, Christodoulou MI, Patapis P, Papadopoulos I, Liakata E, Giagini A, Stavropoulou A, Poulakaki N, Tountas N, Xiros N, Economopoulos T, Pectasides D, Tsitsilonis OE, Pappa V. The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients. Exp Hematol Oncol. 2014 Jan 23;3(1):3. doi: 10.1186/2162-3619-3-3. PMID: 24456704; PMCID: PMC3906764.
Copy Download .nbib Format: NLM
Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group.

Annals of gastroenterology

Kentepozidis N, Economopoulou P, Liontos M, Kotsakis A, Boukovinas I, Vardakis N, Kontopodis E, Prinarakis E, Skaltsi T, Souglakos J, Georgoulias V.
PMID: 30386120
Ann Gastroenterol. 2018 Nov-Dec;31(6):698-704. doi: 10.20524/aog.2018.0311. Epub 2018 Sep 14.

BACKGROUND: A phase I/II study to define the maximum tolerated dose (MTD) of biweekly docetaxel/cisplatin/5-fluorouracil (DCF) plus panitumumab (P), its efficacy, and tolerability as first-line treatment in advanced gastroesophageal cancer.METHODS: In phase I part, patients with unresectable locally advanced...

Cite
Kentepozidis N, Economopoulou P, Liontos M, et al. Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group. Ann Gastroenterol. 2018;31(6):698-704doi: 10.20524/aog.2018.0311.
Kentepozidis, N., Economopoulou, P., Liontos, M., Kotsakis, A., Boukovinas, I., Vardakis, N., Kontopodis, E., Prinarakis, E., Skaltsi, T., Souglakos, J., & Georgoulias, V. (2018). Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group. Annals of gastroenterology, 31(6), 698-704. https://doi.org/10.20524/aog.2018.0311
Kentepozidis, Nikolaos, et al. "Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group." Annals of gastroenterology vol. 31,6 (2018): 698-704. doi: https://doi.org/10.20524/aog.2018.0311
Kentepozidis N, Economopoulou P, Liontos M, Kotsakis A, Boukovinas I, Vardakis N, Kontopodis E, Prinarakis E, Skaltsi T, Souglakos J, Georgoulias V. Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group. Ann Gastroenterol. 2018 Nov-Dec;31(6):698-704. doi: 10.20524/aog.2018.0311. Epub 2018 Sep 14. PMID: 30386120; PMCID: PMC6191861.
Copy Download .nbib Format: NLM
Concomitant Human Herpes Virus 6 and nivolumab-related pneumonitis: Potential pathogenetic insights.

IDCases

Foukas PG, Tsiodras S, Economopoulou P, Spathis A, Mademli M, Leventakos K, Psyrri A, Karakitsos P, Panayiotides IG.
PMID: 29552493
IDCases. 2018 Feb 08;11:101-103. doi: 10.1016/j.idcr.2018.01.013. eCollection 2018.

The development of immune system modulating agents, such as immune checkpoint inhibitors (ICIs), has revolutionized cancer treatment. Nivolumab, a human monoclonal antibody against PD-1, has emerged as an efficient treatment for various malignancies, including non-small cell lung cancer (NSCLC);...

Cite
Foukas PG, Tsiodras S, Economopoulou P, et al. Concomitant Human Herpes Virus 6 and nivolumab-related pneumonitis: Potential pathogenetic insights. IDCases. 2018;11:101-103doi: 10.1016/j.idcr.2018.01.013.
Foukas, P. G., Tsiodras, S., Economopoulou, P., Spathis, A., Mademli, M., Leventakos, K., Psyrri, A., Karakitsos, P., & Panayiotides, I. G. (2018). Concomitant Human Herpes Virus 6 and nivolumab-related pneumonitis: Potential pathogenetic insights. IDCases, 11101-103. https://doi.org/10.1016/j.idcr.2018.01.013
Foukas, Periklis G, et al. "Concomitant Human Herpes Virus 6 and nivolumab-related pneumonitis: Potential pathogenetic insights." IDCases vol. 11 (2018): 101-103. doi: https://doi.org/10.1016/j.idcr.2018.01.013
Foukas PG, Tsiodras S, Economopoulou P, Spathis A, Mademli M, Leventakos K, Psyrri A, Karakitsos P, Panayiotides IG. Concomitant Human Herpes Virus 6 and nivolumab-related pneumonitis: Potential pathogenetic insights. IDCases. 2018 Feb 08;11:101-103. doi: 10.1016/j.idcr.2018.01.013. eCollection 2018. PMID: 29552493; PMCID: PMC5852387.
Copy Download .nbib Format: NLM
Talking the talk: The keys to effective workplace communication.

Bulletin of the American College of Surgeons

Sun RC, Garvey EM, Hogan J, Economopoulos KP.
PMID: 26419050
Bull Am Coll Surg. 2015 Aug;100(8):16-22.

No abstract available.

Cite
Sun RC, Garvey EM, Hogan J, et al. Talking the talk: The keys to effective workplace communication. Bull Am Coll Surg. 2015;100(8):16-22
Sun, R. C., Garvey, E. M., Hogan, J., & Economopoulos, K. P. (2015). Talking the talk: The keys to effective workplace communication. Bulletin of the American College of Surgeons, 100(8), 16-22.
Sun, Raphael C, et al. "Talking the talk: The keys to effective workplace communication." Bulletin of the American College of Surgeons vol. 100,8 (2015): 16-22.
Sun RC, Garvey EM, Hogan J, Economopoulos KP. Talking the talk: The keys to effective workplace communication. Bull Am Coll Surg. 2015 Aug;100(8):16-22. PMID: 26419050.
Copy Download .nbib Format: NLM
Adrenal ganglioneuroma: What you need to know.

World journal of clinical cases

Mylonas KS, Schizas D, Economopoulos KP.
PMID: 29085827
World J Clin Cases. 2017 Oct 16;5(10):373-377. doi: 10.12998/wjcc.v5.i10.373.

Adrenal ganglioneuromas (GNs) constitute rare, differentiated tumors which originate from neural crest cells. GNs are usually hormonally silent and tend to be discovered incidentally on imaging tests. Adrenalectomy is the gold standard for the treatment of primary adrenal GNs....

Cite
Mylonas KS, Schizas D, Economopoulos KP. Adrenal ganglioneuroma: What you need to know. World J Clin Cases. 2017;5(10):373-377doi: 10.12998/wjcc.v5.i10.373.
Mylonas, K. S., Schizas, D., & Economopoulos, K. P. (2017). Adrenal ganglioneuroma: What you need to know. World journal of clinical cases, 5(10), 373-377. https://doi.org/10.12998/wjcc.v5.i10.373
Mylonas, Konstantinos S, et al. "Adrenal ganglioneuroma: What you need to know." World journal of clinical cases vol. 5,10 (2017): 373-377. doi: https://doi.org/10.12998/wjcc.v5.i10.373
Mylonas KS, Schizas D, Economopoulos KP. Adrenal ganglioneuroma: What you need to know. World J Clin Cases. 2017 Oct 16;5(10):373-377. doi: 10.12998/wjcc.v5.i10.373. PMID: 29085827; PMCID: PMC5648998.
Copy Download .nbib Format: NLM
Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents.

Journal of materials chemistry. B

Soleimani A, Martínez F, Economopoulos V, Foster PJ, Scholl TJ, Gillies ER.
PMID: 32262367
J Mater Chem B. 2013 Feb 21;1(7):1027-1034. doi: 10.1039/c2tb00352j. Epub 2012 Dec 18.

Polymer cross-linking was explored as an approach for increasing the relaxivity of macromolecular contrast agents for magnetic resonance imaging. Poly(ethylene glycol) methyl ether methacrylate, N-(2-aminoethyl)methacrylamide hydrochloride, and the cross-linker ethylene glycol dimethacrylate were copolymerized under free radical conditions. By...

Cite
Soleimani A, Martínez F, Economopoulos V, et al. Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents. J Mater Chem B. 2012;1(7):1027-1034doi: 10.1039/c2tb00352j.
Soleimani, A., Martínez, F., Economopoulos, V., Foster, P. J., Scholl, T. J., & Gillies, E. R. (2013). Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents. Journal of materials chemistry. B, 1(7), 1027-1034. https://doi.org/10.1039/c2tb00352j
Soleimani, Abdolrasoul, et al. "Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents." Journal of materials chemistry. B vol. 1,7 (2013): 1027-1034. doi: https://doi.org/10.1039/c2tb00352j
Soleimani A, Martínez F, Economopoulos V, Foster PJ, Scholl TJ, Gillies ER. Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents. J Mater Chem B. 2013 Feb 21;1(7):1027-1034. doi: 10.1039/c2tb00352j. Epub 2012 Dec 18. PMID: 32262367.
Copy Download .nbib Format: NLM
Preoperative Intra-articular Steroid Injections as Predictors of Hip Arthroscopy: 2-Year Outcomes.

Orthopaedic journal of sports medicine

Mujahed T, Hassebrock JD, Makovicka JL, Pollock JR, Wilcox JG, Patel KA, Economopoulos KJ.
PMID: 34881337
Orthop J Sports Med. 2021 Nov 29;9(11):23259671211053817. doi: 10.1177/23259671211053817. eCollection 2021 Nov.

BACKGROUND: In patients with femoroacetabular impingement, preoperative diagnostic injections are commonly used to establish a diagnosis of intra-articular pathology. In some cases, intra-articular steroid injections are also used for therapeutic purposes.PURPOSE/HYPOTHESIS: The purpose of this study was to determine...

Cite
Mujahed T, Hassebrock JD, Makovicka JL, et al. Preoperative Intra-articular Steroid Injections as Predictors of Hip Arthroscopy: 2-Year Outcomes. Orthop J Sports Med. 2021;9(11):23259671211053817doi: 10.1177/23259671211053817.
Mujahed, T., Hassebrock, J. D., Makovicka, J. L., Pollock, J. R., Wilcox, J. G., Patel, K. A., & Economopoulos, K. J. (2021). Preoperative Intra-articular Steroid Injections as Predictors of Hip Arthroscopy: 2-Year Outcomes. Orthopaedic journal of sports medicine, 9(11), 23259671211053817. https://doi.org/10.1177/23259671211053817
Mujahed, Tala, et al. "Preoperative Intra-articular Steroid Injections as Predictors of Hip Arthroscopy: 2-Year Outcomes." Orthopaedic journal of sports medicine vol. 9,11 (2021): 23259671211053817. doi: https://doi.org/10.1177/23259671211053817
Mujahed T, Hassebrock JD, Makovicka JL, Pollock JR, Wilcox JG, Patel KA, Economopoulos KJ. Preoperative Intra-articular Steroid Injections as Predictors of Hip Arthroscopy: 2-Year Outcomes. Orthop J Sports Med. 2021 Nov 29;9(11):23259671211053817. doi: 10.1177/23259671211053817. eCollection 2021 Nov. PMID: 34881337; PMCID: PMC8647274.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 78 entries